13-15 March 2017
For The Cure Parkinson's Trust
Curated by Susie Allen & Laura Culpan, Artwise
In Partnership with Bonhams
Supported by The David Ross Foundation and London's Gatwick Airport
Words from Tom Isaacs
CPT President and Co-Founder, 2005-2017
The Cure Parkinson's Trust (CPT) could not be more delighted to be involved with the Cure3 project. We have been bowled over by the extraordinary enthusiasm of the people involved. The success of the project is indicative of the wealth of talent and expertise of those who have defined and shaped the project from the outset.
The Cure Parkinson’s Trust was set up in 2005 by four people living with the condition with the bold aim to find a cure. We fund innovative projects and inspirational scientists with the potential to accelerate a breakthrough in the treatment of the condition for the estimated 10 million people around the world who currently live with this disease.
The money raised from Cure3 will be channelled directly into clinical trials funded by CPT on treatments that have the capacity to slow, stop, or reverse Parkinson's, as prioritised by our scientific team, which comprises the most renowned names in the field.
In our short history, CPT has become recognised as a global force in the Parkinson’s research community. The charity is widely respected for focusing on making a tangible, permanent and significant impact on people’s lives within a five-year period.
We are single-minded and determined in our approach to improve people’s lives. To achieve this, our activities are defined by people who live with this cruel, progressive, and all-consuming neurological condition. Parkinson's can affect everything in life that most people take for granted. It affects people physically, mentally, behaviourally, and emotionally. We urgently need to find new treatments. This is what The Cure Parkinson's Trust was set up to do.
The charity is making significant progress towards its goal, and throughout 2017 we will be delivering a series of important announcements that reflect the calibre and magnitude of innovative scientific discovery. These are breakthroughs for which our activities have been instrumental. To continue this work, we rely on funding from events such as this one, not only to raise crucial funds to support our cutting-edge activities, but also to raise the profile of Parkinson's, which is so important in communicating our overall quest for a cure.
Excerpt from the Cure3 2017 catalogue, published March 2017 for the occasion of the launch exhibition.